Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression - ScienceDirect
Summary of unboosted and ritonavir-boosted PI dose regimens | Download Table
How Ritonavir acts as booster drug - YouTube
Paxlovid (Nirmatrelvir-Ritonavir) contro Covid-19 - Network Bibliotecario Sanitario Toscano
Hivus-LR Lopinavir Ritonavir Tablets Ip, Prescription, Treatment: Hiv,Immunity Booster
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Ritonavir | C37H48N6O5S2 | CID 392622 - PubChem
Evidence-Based Recommendations on the Use of Nirmatrelvir/Ritonavir (Paxlovid) for Adults in Ontario - Ontario COVID-19 Science Advisory Table
Paxlovid Ritonavir Boosted Nirmatrelvir 150 Mg 100 Mg
Ritonavir - Wikipedia
Ritonavir ≥98% (HPLC) | 155213-67-5
Norvir (Ritonavir) for HIV: Dosage, Side Effects, and More
Lopinavir/ritonavir - Wikipedia
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Atazanavir Ritonavir,Synthivan Tablet | Rizochem Pharmaceuticals | Export
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study - The Lancet HIV
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins - ScienceDirect
Implications of the Digestion of Milk-Based Formulations for the Solubilization of Lopinavir/Ritonavir in a Combination Therapy | Molecular Pharmaceutics
Structures of the boosters (CYP inhibitors) ritonavir and cobicistat,... | Download Scientific Diagram
Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice | Molecular Pharmaceutics
The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins - ScienceDirect
